Skip to main navigation Skip to search Skip to main content

Pharmaceutical industry payments and prescriptions of direct acting antiviral drugs for hepatitis C virus infection

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish
Pages (from-to)3274-3278
Number of pages5
JournalLiver International
Volume44
Issue number12
DOIs
StatePublished - Dec 2024

Keywords

  • Medicare
  • United States
  • conflicts of interest
  • direct acting antiviral
  • health policy
  • hepatitis C virus infection
  • profession

Cite this